GO
Loading...

Pfizer Inc

More

  • Final Glance: Pharmaceuticals companies Tuesday, 23 Sep 2014 | 6:03 PM ET

    Baxter International Inc. fell$. 35 or. 5 percent, to $71.72. Bristol-Myers Squibb Co. fell$. 38 or. 7 percent, to $51.29. Eli Lilly& Co. fell$. 13 or. 2 percent, to $65.95.

  • Sept 23- Pfizer Inc has approached Dublin- based generic drugmaker Actavis Plc to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter. The companies are not currently in formal talks and Pfizer has not made an offer, the Bloomberg report said.

  • *Action may deter Pfizer from returning to bid for AstraZeneca. WASHINGTON/ NEW YORK, Sept 23- Tough new U.S. rules on corporate "inversions" on Tuesday sent a chill through the market for the tax-avoidance deals, both pending and potential, with share prices falling sharply in nearly a dozen companies on both sides of the Atlantic.

  • Midday Glance: Pharmaceuticals companies Tuesday, 23 Sep 2014 | 1:20 PM ET

    Baxter International Inc. fell$. 39 or. 5 percent, to $71.68. Bristol-Myers Squibb Co. fell$. 34 or. 7 percent, to $51.33. Hospira fell$. 28 or. 5 percent, to $52.18.

  • Most active New York Stock Exchange-traded stocks Tuesday, 23 Sep 2014 | 1:20 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AbbVie fell 2.0 percent to $57.56 with 21,744,100 shares traded. Bank of America Corp. rose. 1 percent to $17.05 with 89,952,800 shares traded.

  • *Raiffeisen Bank tumbles after warning on Ukraine, Hungary. Austria's Raiffeisen Bank International, down 10 percent, led the declines on the FTSEurofirst 300 index. The bank said it might lose as much as 500 million euros this year because of problems in Ukraine and Hungary.

  • *Action may deter Pfizer from returning to bid for AstraZeneca. Burger King, which is in the process of an inversion deal with Canada's Tim Horton's, said Tuesday it would proceed with its $11.5 billion deal despite the Treasury actions, saying the transaction was not about the tax benefits.

  • US clampdown on tax maneuver leaves its mark Tuesday, 23 Sep 2014 | 12:00 PM ET

    The pharmaceutical company AbbVie, based in Chicago, reached an agreement to buy Dublin- based Shire in July for $54 billion. AbbVie Inc. lost 2 percent in New York trading, while Shire sank 2 percent in London. said Jan Wald, an analyst at Benchmark Co., a financial advisory firm.

  • Disappointing economic data sends European shares lower Tuesday, 23 Sep 2014 | 11:04 AM ET

    *Raiffeisen Bank tumbles after warning on Ukraine, Hungary. Shares in Austria's Raiffeisen Bank International, down 8.8 percent, were the biggest faller in the FTSEurofirst 300 index, after the lender said it could lose as much as 500 million euros this year because of problems in Ukraine and Hungary.

  • Early Glance: Pharmaceuticals companies Tuesday, 23 Sep 2014 | 10:29 AM ET

    Baxter International Inc. fell$. 14 or. 2 percent, to $71.93. Bristol-Myers Squibb Co. fell$. 20 or. 4 percent, to $51.47. Hospira fell$. 50 or 1.0 percent, to $51.96.

  • European shares drop on disappointing economic data Tuesday, 23 Sep 2014 | 7:53 AM ET

    *Raiffeisen Bank sinks after warning on Ukraine, Hungary. Shares in Austria's Raiffeisen Bank International, down 12 percent, were the biggest faller in the FTSEurofirst 300 index, after the lender said hits from Ukraine and Hungary will probably push it to its first-ever annual loss this year.

  • *May deter Pfizer from returning to bid for AstraZeneca. LONDON, Sept 23- Shares in drugmakers AstraZeneca and Shire fell sharply on Tuesday after the U.S. The move could jeopardize an agreed deal for AbbVie to buy Shire for $55 billion and deter Pfizer from making another attempt to acquire AstraZeneca, after a $118 billion takeover attempt failed in May.

  • *May deter Pfizer from returning to bid for AstraZeneca. LONDON, Sept 23- Shares in drugmakers AstraZeneca and Shire both fell more than 5 percent on Tuesday after the U.S.

  • *Raiffeisen Bank sinks after warning on Ukraine, Hungary. Shares in Raiffeisen Bank International featured among the top losers, down 10 percent after the Austrian lender said hits from Ukraine and Hungary will likely push it to its first-ever annual loss in 2014..

  • Europe, Syria drag on global stock markets Tuesday, 23 Sep 2014 | 4:09 AM ET

    NEW YORK— Grim economic news from Europe and airstrikes in Syria rattled global stocks Tuesday. Investors have been dealing with meager economic growth in Europe for months. "It has a very feeble recovery going on that is vulnerable to even the slightest external shock," said Jacob Kirkegaard, senior fellow at the Peterson Institute for International Economics.

  • LONDON, Sept 23- Shares in drugmakers AstraZeneca and Shire both fell more than 5 percent on Tuesday after the U.S. The move appears to jeopardise an agreed deal for AbbVie to buy Shire for $55 billion and could deter Pfizer from making another attempt to acquire AstraZeneca, after a $118 billion takeover attempt failed in May.

  • Final Glance: Pharmaceuticals companies Monday, 22 Sep 2014 | 6:03 PM ET

    Baxter International Inc. fell$. 47 or. 6 percent, to $72.07. Bristol-Myers Squibb Co. rose$. 16 or. 3 percent, to $51.67. Hospira fell $1.39 or 2.6 percent, to $52.46.

  • Treasury takes actions to deter tax inversions Monday, 22 Sep 2014 | 6:00 PM ET
    Jack Lew

    The issue of so-called tax inversions has been a major policy point for President Barack Obama over the past few months.

  • Midday Glance: Pharmaceuticals companies Monday, 22 Sep 2014 | 2:12 PM ET

    Baxter International Inc. fell$. 63 or. 9 percent, to $71.91. Bristol-Myers Squibb Co. rose$. 20 or. 4 percent, to $51.71. Hospira fell $1.31 or 2.4 percent, to $52.54.

  • Most active New York Stock Exchange-traded stocks Monday, 22 Sep 2014 | 2:12 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Alcoa Inc. fell 2.3 percent to $15.83 with 22,421,800 shares traded. Alpha Natural Resources Inc. fell 9.4 percent to $2.70 with 22,178,100 shares traded.